![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/hanall-biopharma-signs-licensing-agreement-with-turn-biotechnologies-to-develop-novel-treatments-for-eye-and-ear-diseases-302156468.html
https://www.contractpharma.com/contents/view_breaking-news/2024-05-28/hanall-signs-exclusive-licensing-agreement-with-turn-biotechnologies/?widget=listSection
https://www.prnewswire.com/news-releases/turn-biotechnologies-shows-promise-of-epigenetic-reprogramming-to-rejuvenate-skin-at-season-aesthetic-conference-301811888.html
https://www.prnewswire.com/news-releases/turn-biotechnologies-to-present-at-the-guggenheim-healthcare-talks-genomic-medicines-and-rare-disease-days-301789181.html